𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Resistance ofHistoplasma capsulatumto killing by human neutrophils

✍ Scribed by Nobuyuki Kurita; Kiyoshi Terao; Elmer Brummer; Emiko Ito; Kazuko Nishimura; Makoto Miyaji


Book ID
104780698
Publisher
Springer Netherlands
Year
1991
Tongue
English
Weight
958 KB
Volume
115
Category
Article
ISSN
0301-486X

No coin nor oath required. For personal study only.

✦ Synopsis


The basis for resistance of yeast form of Histoplasma capsulatum to antifungal activity of human neutrophils was studied. In limiting dilution assays and short term coculture assays human neutrophils were ineffective in killing H. capsulatum whereas Candida albicans was readily killed. By contrast, in a cell free hydrogen peroxide-peroxidase-halide system H. capsulatum was as sensitive to killing as C. albicans. Moreover, lysate of human neutrophils effectively substituted for horse-radish peroxidase in a cell free system for killing H. capsulatum. H. capsulatum elicited significant products of the oxidative burst in human neutrophils as detected by luminol-enhanced chemiluminescence. However, the response was two-fold less (p less than 0.05) than that induced by C. albicans. Transmission electron microscopy studies showed that phagosome-lysosome fusion took place when neutrophils phagocytosed C. albicans or H. capsulatum. Taken together, these findings indicate that, even though H. capsulatum elicits an oxidative burst and phagosome-lysosome fusion within the phagosome, it is capable of evading damage in short term assays.


πŸ“œ SIMILAR VOLUMES


Direct killing of interleukin-2-transfec
✍ Federica Pericle; Robert A. Kirken; P. K. Epling-Burnette; D. Kay Blanchard; Jul πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 885 KB

We have previously established that human polymorphonuclear cells (PMN) express IL-2R beta- and gamma-chains and that addition of IL-2 maintains the viability of PMN by preventing these cells from undergoing programmed cell death. The purpose of this study was to examine whether IL-2-releasing tumor